News Synairgen under the weather after AZ halts asthma trial AZ assessing drug's future following trial disappointment.
News Faron moves ahead with "shock lung" drug Finnish firm eyes first drug for acute respiratory distress syndrome.
News Biomarker trial to show drug value in rare lung disease Growing incidence of IPF raises need for better means of determining diagnosis and treatment success.
News Novartis Breezhaler bests GSK's Seretide in COPD Ultibro showed consistent reductions in rate of all exacerbations, whether mild, moderate, or severe.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.